Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer von Nelson, Joel B., Love, William, Chin, Joseph L., Saad, Fred, Schulman, Claude C., Sleep, Darryl J., Qian, Jiang, Steinberg, Joyce, Carducci, Michael

Volltext

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer von Carducci, Michael A., Saad, Fred, Abrahamsson, Per‐Anders, Dearnaley, David P., Schulman, Claude C., North, Scott A., Sleep, Darryl J., Isaacson, Jeffrey D., Nelson, Joel B.

Volltext

Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study von Mohiuddin, Syed M., MD, Pepine, Carl J., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed Dyslipidemia von Goldberg, Anne C., MD, Bays, Harold E., MD, Ballantyne, Christie M., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study von Jones, Peter H, Davidson, Michael H, Kashyap, Moti L, Kelly, Maureen T, Buttler, Susan M, Setze, Carolyn M, Sleep, Darryl J, Stolzenbach, James C

Volltext

Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans von Zhu, Tong, Ansquer, Jean-Claude, Kelly, Maureen T., Sleep, Darryl J., Pradhan, Rajendra S.

Volltext

A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-Resistant Metastatic Prostate Cancer von ARMSTRONG, Andrew J, CREEL, Patricia, HURWITZ, Herbert, GEORGE, Daniel J, TURNBULL, James, MOORE, Cassandra, JAFFE, Tracya, HALEY, Sherri, PETROS, William, YENSER, Sarah, GOCKERMAN, Jon P, SLEEP, Darryl

Volltext

Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia von Jones, Peter H., MD, Goldberg, Anne C., MD, Knapp, Howard R., MD, PhD, Kelly, Maureen T., MD, Setze, Carolyn M., MS, Stolzenbach, James C., PhD, Sleep, Darryl J., MD

Volltext

Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients von Wu, Eric Q., PhD, Mulani, Parvez, MS, CPhil, Farrell, Max H., BS, Sleep, Darryl, MD, MBBCh, FCS

Volltext

Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia von Goldberg, Anne C., MD, Bittner, Vera, MD, MSPH, Pepine, Carl J., MD, Kelly, Maureen T., MD, Thakker, Kamlesh, BPharm, PhD, Setze, Carolyn M., MS, Lele, Aditya, MS, Sleep, Darryl J., MD

Volltext

The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia von BAYS, Harold E, ROTH, Eli M, MCKENNEY, James M, KELLY, Maureen T, THAKKER, Kamlesh M, SETZE, Carolyn M, OBERMEYER, Katie, SLEEP, Darryl J

Volltext

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia von Bays, Harold E., MD, Jones, Peter H., MD, Mohiuddin, Syed M., MD, Kelly, Maureen T., MD, Sun, Hsiaoming, MS, Setze, Carolyn M., MS, Buttler, Susan M., BS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan von Xiong, Hao, Carr, Robert A., Locke, Charles S., Katz, David A., Achari, Ramanuj, Doan, Thao T., Wang, Perry, Jankowski, James R., Sleep, Darryl J.

Volltext

ABT-335, the Choline Salt of Fenofibric Acid, Does Not Have a Clinically Significant Pharmacokinetic Interaction With Rosuvastatin in Humans von Zhu, Tong, Awni, Walid M., Hosmane, Balakrishna, Kelly, Maureen T., Sleep, Darryl J., Stolzenbach, James C., Wan, Katty, Chira, Titus O., Pradhan, Rajendra S.

Volltext

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgr... von Jones, Peter H., Cusi, Kenneth, Davidson, Michael H., Kelly, Maureen T., Setze, Carolyn M., Thakker, Kamlesh, Sleep, Darryl J., Stolzenbach, C.

Volltext

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies von Jones, Peter H., MD, Davidson, Michael H., MD, Goldberg, Anne C., MD, Pepine, Carl J., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Lele, Aditya, MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Evaluation of a New Formulation of Fenofibric Acid, ABT-335,Co-Administered with Statins: Study Design and Rationale of a Phase III Clinical Programme von Jones, Peter H., Bays, Harold E., Davidson, Michael H., Kelly, Maureen T., Buttler, Susan M., Setze, Carolyn M., Sleep, Darryl J., Stolzenbach, James C.

Volltext

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study von Kipnes, Mark S., Roth, Eli M., Rhyne, James M., Setze, Carolyn M., Lele, Aditya, Kelly, Maureen T., Sleep, Darryl J., Stolzenbach, James C.

Volltext

Effects of Visual Sexual Stimuli and Apomorphine SL on Cerebral Activity in Men with Erectile Dysfunction von Hagemann, Jörn H, Berding, Georg, Bergh, Sven, Sleep, Darryl J, Knapp, Wolfram H, Jonas, Udo, Stief, Christian G

Volltext

Long-Term Efficacy of Rosuvastatin and Fenofibric Acid 20 mg/135 mg in Dyslipidemic Patients Initially Treated with Rosuvastatin and Fenofibric Acid 10 mg/135 mg von Ferdinand, Keith C., MD, Davidson, Michael H, Kelly, Maureen T, Setze, Carolyn M, Schiebinger, Rick, Sleep, Darryl J

Volltext